Research Journal of Pharmacy and Technology

Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Ketoconazole: A Re-emerging Choice for Oral Candidiasis in Patients with Human Immunodeficiency Virus Infection/Acquired Immunodeficiency Syndrome


Affiliations
1 Department of Dermatology and Venereology, Faculty of Medicine, Universitas Airlangga, Dr. Soetomo General Hospital, Surabaya 60285,, Indonesia
2 Universitas Airlangga Teaching Hospital, Surabaya 60115, Indonesia
     

   Subscribe/Renew Journal


Background: The long term use of antifungals for oral candidiasis (OC) in patients with Human Immunodeficiency Virus (HIV) and Acquired Immune Deficiency Syndrome (AIDS) causes some strains to be resistant to certain antifungals. HIV/AIDS are currently most common in men. Aim: To evaluate ketoconazole sensitivity on Candida species in male HIV/AIDS patients with OC. Method: This is an observational descriptive study at the Outpatient Unit and Inpatient Installation of the Infectious Disease Intermediate Care Unit (UPIPI) Dr. Soetomo, Surabaya. Samples were taken from HIV/AIDS male patients with OC using sterile swabs. The smear was cultured in CHROMagar Candida incubated at 37°C for 48-72 hours, and Sabouraud Dextrose Agar media for 48 hours at 28°C. Species identification were done using carbohydrate and Cornmeal test. Resistance test was done by disk diffusion method. Results: There were 23 research subjects with 40 isolates of Candida species growing in culture. The most common species was C. albicans in 23(57.5%) isolates, while Candida non-albicans were found in 17(42.5%) isolates. The sensitivity test results showed that 34 (85%) isolates were sensitive, while 2(5%) isolates were resistant to ketoconazole. All C. albicans (23 [100%]) and most Candida non-albicans species (11 [64%]) were sensitive to ketoconazole. Conclusion: Ketoconazole can be recommended as a treatment option for OC patients with HIV/AIDS due to the high sensitivity of both C. albicans and non-albicans to this drug.

Keywords

Ketoconazole, Antifungal agents, Candidiasis, oral, Drug resistance, Fungal, HIV.
Subscription Login to verify subscription
User
Notifications
Font Size


  • Moges B, Bitew A, and Shewaamare A. Spectrum and the in vitro antifungal susceptibility pattern of yeast isolates in Ethiopian HIV patients with oropharyngeal candidiasis. International Journal of Microbiology. 2016; 2016: 1-8.

  • Varshan R, Gopinath P. Characterization and biofilm detection among clinically important Candida species. Research Journal of Pharmacy and Technology. 2016; 9(9): 1375-1378

  • Sangamithra V, Verma R, Sengottuvelu S, Sumathi R. Candida infections of the genitourinary tract. Research Journal of Pharmacy and Technology. 2013; 6(10): 1110-1115

  • Charyulu RN, Devi PP, Jose J, Shetty AV. Formulation and evaluation of mucoadhesive oral gel containing miconazole nitrate for oral candidiasis. Research Journal of Pharmacy and Technology. 2013; 6(11): 1251-1257

  • Kundu RV, and Garg A. Yeast infection: tinea (pityriasis) versicolor, Malassezia (pityrosporum) folliculitis. In Fitzpatrick’s Dermatology in General Medicine. Edited by Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell D, and Wolff K. McGraw-Hill, New York. 2012; 8th ed: pp. 2298-2311.

  • Jangir N, Bakshi S, Vyas N. Isolation and detection of Aspergillus and Candida species in sputum of HIV positive patients and it correlate with CD4. Research Journal of Pharmacy and Technology. 2012; 5(6): 785-788

  • Uihlein L, Saavedra AP, and Johnson RA. Cutaneous manifestations of human immunodeficiency virus disease. In Fitzpatrick’s Dermatology in General Medicine. Edited by Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell D, and Wolff K. McGraw-Hill, New York. 2012; 8th ed: pp. 4574-4575.

  • Reza NR, Sugiman T, and Basuki S. Uji kepekaan in vitro flukonazol terhadap spesies Candida penyebab kandidiasis oral pada pasien HIV/AIDS dengan Vitek II. BIKKK - Berkala Ilmu Kesehatan Kulit dan Kelamin - Periodical of Dermatology and Venereology. 2017; 29(3): 234-242.

  • Ahmed LT. Genotyping and antifungal susceptibility of C. albicans isolated from infected woman. Research Journal of Pharmacy and Technology. 2019; 12(11): 5171-5176

  • Suyoso S, Ervianti E, and Barakbah J. Kandidiasis mukosa. In Panduan praktik klinis SMF Ilmu Kesehatan Kulit dan Kelamin RSUD Dr. Soetomo, Surabaya. Edited by Suyoso S, Ervianti E, and Barakbah J. SMF. Ilmu Kesehatan Kulit dan Kelamin RSUD. Dr. Soetomo, Surabaya. 2014; pp.95-97.

  • Wahyuli HN, Suyoso S, and Prakoeswa CRS. Manifestasi klinis dan identifikasi spesies penyebab kandidiasis oral pada pasien HIV/AIDS di RSUD dr. Soetomo Surabaya. BIKKK - Berkala Ilmu Kesehatan Kulit dan Kelamin - Periodical of Dermatology and Venereology. 2010; 22: 11-6.

  • Sobel JD, and Akins RA. The role of resistance in Candida infections: epidemiology and treatment. In Antimicrobial Drug Resistance. Edited by Mayers D, Sobel JD, Ouellette M, Kaye KS, and Marchaim D. Springer International Publishing; Cahm. 2017; 2nd ed: pp. 1075-1097

  • Pandey M, Sharma S, Mishra SK. Evaluation of blood stream infection caused by Candida albicans. Research Journal of Pharmacy and Technology. 2014; 6(3): 139-140

  • Kadry AA, El-Ganiny AM, El-Baz AM. Comparison of methods used in identification of Candida albicans. Research Journal of Pharmacy and Technology. 2018; 11(3): 1164-1168

  • Infodatin Pusat Data dan Informasi Kementerian Kesehatan RI. Situasi penyakit HIV AIDS di Indonesia. Available from: URL: http://www.pusdatin.kemenkes.go.id

  • Yowel, Waluyo A, and Kuntarti K. Umur orang dengan HIV AIDS (ODHA) berhubungan dengan tindakan pencegahan penularan HIV. Jurnal Keperawatan Indonesia. 2016; 19(3):200-7.

  • Bajomo AS, Ayo-Yusuf OA, and Rudolph MJ, Tsotsi NM. Impact of oral lesions among South African adult with HIV/AIDS on oral health-related quality of life. Journal of Dental Sciences. 2013; 8: 412-7.

  • Dinas Kesehatan Provinsi Jawa Timur. Profil kesehatan provinsi Jawa Timur tahun 2013. Available from: URL: http:// www.depkes.go.id/resources/download/profil/PROFIL_KES_PROVINSI_2013/15_Prov_Jatim_2013.pdf

  • Maurya V, Srivastava A, Mishra J, Gaind R, Marak RSK, Tripathi AK, et al. Oropharyngeal candidiasis and Candida colonization in HIV positive patients in northern India. The Journal of Infection in Developing Countries. 2013; 7(8): 608-13

  • Patel PK, Erlandsen JE, Kirkpatrick WR, Berg DK, Westbrook SD, Louden C, et al. The changing epidemiology of oropharyngeal candidiasis in patients with HIV/AIDS in the era of antiretroviral therapy. AIDS Research and Treatment. 2012; 262471

  • Sariguzel FM, Berk E, Koc A, Sav H, and Aydemir G. Evaluation of CHROMagar Candida, Vitek 2 YST and Vitek MS for identification of Candida strains isolated from blood cultures. Le Infezioni in Medicina. 2015; 23(4): 318-22

  • Tamizh PT, Gopinath P. Differentiation of Candida dubliniensis on CHROM agar and Pal’s agar. Research Journal of Pharmacy and Technology. 2016; 9(12): 2150-2154

  • Anuradha V, Praveena A, Habeeb SKM, Madan. Identification of drug targets through mutational analysis of drug resistance genes in Candida albicans. Research Journal of Pharmacy and Technology. 2013; 6(3): 267-277

  • Mushi MF, Mtemisika CI, Bader O, Bii C, Mirambo MM, Gro U, et al. High oral carriage of non-albicans Candida spp. among HIV-infected individuals. International Journal of Infectious Diseases. 2016; 49: 185-8

  • Prasanna GE, Gopinath P. Characterization and detection of biofilm among clinical isolates of Candida species by tube method. Research Journal of Pharmacy and Technology. 2016; 9(12): 2109-2112

  • Njunda AL, Nsagha DS, Assob JCN, Kamga HL, and Teyim P. In vitro antifungal susceptibility patterns of Candida albicans from HIV and AIDS patients attending the Nylon Health District Hospital in Douala, Cameroon. Journal of Public Health in Africa. 2012; 3: 1-4


Abstract Views: 91

PDF Views: 0




  • Ketoconazole: A Re-emerging Choice for Oral Candidiasis in Patients with Human Immunodeficiency Virus Infection/Acquired Immunodeficiency Syndrome

Abstract Views: 91  |  PDF Views: 0

Authors

Dwi Murtiastutik
Department of Dermatology and Venereology, Faculty of Medicine, Universitas Airlangga, Dr. Soetomo General Hospital, Surabaya 60285,, Indonesia
M. Yulianto Listiawan
Department of Dermatology and Venereology, Faculty of Medicine, Universitas Airlangga, Dr. Soetomo General Hospital, Surabaya 60285,, Indonesia
Lunardi Bintanjoyo
Department of Dermatology and Venereology, Faculty of Medicine, Universitas Airlangga, Dr. Soetomo General Hospital, Surabaya 60285,, Indonesia
Afif Nurul Hidayati
Universitas Airlangga Teaching Hospital, Surabaya 60115, Indonesia
Septiana Widyantari
Department of Dermatology and Venereology, Faculty of Medicine, Universitas Airlangga, Dr. Soetomo General Hospital, Surabaya 60285,, Indonesia
Astindari
Department of Dermatology and Venereology, Faculty of Medicine, Universitas Airlangga, Dr. Soetomo General Hospital, Surabaya 60285,, Indonesia
Maylita Sari
Department of Dermatology and Venereology, Faculty of Medicine, Universitas Airlangga, Dr. Soetomo General Hospital, Surabaya 60285,, Indonesia

Abstract


Background: The long term use of antifungals for oral candidiasis (OC) in patients with Human Immunodeficiency Virus (HIV) and Acquired Immune Deficiency Syndrome (AIDS) causes some strains to be resistant to certain antifungals. HIV/AIDS are currently most common in men. Aim: To evaluate ketoconazole sensitivity on Candida species in male HIV/AIDS patients with OC. Method: This is an observational descriptive study at the Outpatient Unit and Inpatient Installation of the Infectious Disease Intermediate Care Unit (UPIPI) Dr. Soetomo, Surabaya. Samples were taken from HIV/AIDS male patients with OC using sterile swabs. The smear was cultured in CHROMagar Candida incubated at 37°C for 48-72 hours, and Sabouraud Dextrose Agar media for 48 hours at 28°C. Species identification were done using carbohydrate and Cornmeal test. Resistance test was done by disk diffusion method. Results: There were 23 research subjects with 40 isolates of Candida species growing in culture. The most common species was C. albicans in 23(57.5%) isolates, while Candida non-albicans were found in 17(42.5%) isolates. The sensitivity test results showed that 34 (85%) isolates were sensitive, while 2(5%) isolates were resistant to ketoconazole. All C. albicans (23 [100%]) and most Candida non-albicans species (11 [64%]) were sensitive to ketoconazole. Conclusion: Ketoconazole can be recommended as a treatment option for OC patients with HIV/AIDS due to the high sensitivity of both C. albicans and non-albicans to this drug.

Keywords


Ketoconazole, Antifungal agents, Candidiasis, oral, Drug resistance, Fungal, HIV.

References